Are anti-nuclear antibodies common in affective disorders? A review of the past 35 years

Psychosomatics

Volumn 48, Issue 4, 2007, Pages 286-289

  Appleby, Brian ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTINUCLEAR ANTIBODY; SERTRALINE; VENLAFAXINE;

ADULT; ANTIBODY TITER; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONFOUNDING VARIABLE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOASSAY; LABORATORY DIAGNOSIS; MAJOR DEPRESSION; MOOD DISORDER; REVIEW; RISK FACTOR;

EID: 34347209968     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.48.4.286     Document Type: Review

References (21)

1. Wilk AS: Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand J Rheumatol 2005; 34:260-268
2. Gastpar M, Muller W: Auto-antibodies in affective disorders. Neuropsychopharmacol 1981; 5:91-97
3. Ghose K, Coppen A, Hurdle ADF, et al: Antinuclear antibodies, affective disorders, and lithium therapy. Pharmakopsychiat 1977; 10:243-245
4. Kavanaugh A, Tomar R, Reveille J, et al: Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med 2000; 124:71-81
5. von Brauchitsch H: Antinuclear factor in psychiatric disorders. Am J Psychiatry 1972; 12:102-104
6. Deberdt R, Van Hooren J, Biesbrouck M, et al: Antinuclear factor-positive mental depression: a single disease entity? Biol Psychiatry 1976; 11:69-74
7. Johnstone E, Whaley K: Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment. BMJ 1975; 2:724-725
8. Legros S, Mendlewicz J, Wybran J: Immunoglobulins, autoantibodies, and other serum protein fractions in psychiatric disorders. Eur Arch Rsychiatr Neurol Sci 1985; 235:9-11
9. Hornig M, Amsterdam J, Kamoun M, et al: Autoantibody disturbances in affective disorders: a function of age and gender? J Affect Disord 1999; 55:29-37
10. Shopsin B, Sathananthan GL, Chan TL, et al: Antinuclear factor in psychiatric patients. Biol Psychiatry 1973; 7:81-87
11. van Dam AP, Wekking EM, Callewaert JAC, et al: Psychiatric symptoms before systemic lupus erythematosus is diagnosed. Rheumatol Int 1994; 14:57-62
12. de Vries E, Schipperijn AJM, Breedveld FC: Antinuclear antibodies in psychiatric patients. Acta Psychiatr Scand 1994; 89:289-290
13. Plantey F: Antinuclear factor in affective disorders. Biol Psychiatry 1978; 13:149-150
14. Fontana A, Storck U, Angst J, et al: An immunological basis of schizophrenia and affective disorders? Neuropsychobiology 1980; 6:284-289
15. Berglund S, Gottfries CG, Gottfries I, et al: Chlorpromazine-induced antinuclear factors. Acta Med Scand 1970; 187:67-74
16. Katz PP, Yelin EH: Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis. J Rheumatol 1993; 20:790-796
17. Moran MG: Psychiatric aspects of rheumatology. Psychiatr Clin Am 1996; 19:575-587
18. Harris E (ed): Kelley's Textbook of Rheumatology, 7th Edition. Philadelphia, PA, WB Saunders, 2005, pp 1204-1205
19. Moore D, Jefferson J: Handbook of Medical Psychiatry, 2nd Edition. Philadelphia, PA, Mosby, 2004, p 294
20. Rakel R (ed): Textbook of Family Practice, 6th Edition. Philadelphia, PA, WB Saunders, 2002, p 979
21. Goldman L, Ausiello D (ed): Cecil Textbook of Medicine, 22nd Edition. Philadelphia, PA, WB Saunders, 2004, p 1667